Journal of Nanomaterials / 2019 / Article / Fig 5

Research Article

TfR mAb-Cross-Linked Rituximab/MTX-PEG-PLL-PLGA Drug-Loaded Nanoparticles Enhance Anticancer Action in B Lymphocytes

Figure 5

(a) Cell cycle analysis of SU-DHL-4 cells treated by different kinds of drug for 48 hours using flow cytometry. (b) The percentages of phases in the cell cycle are shown as the . ; .
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.